Latest News

Keep up to date with the latest news from Pilatus Biosciences.

News

May 5, 2026

Pilatus Biosciences Announces Formation of Scientific Advisory Board

April 8, 2026

Pilatus Biosciences to Present New Data Highlighting Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Cancer at AACR 2026

March 12, 2026

Pilatus Biosciences Announces First Patient Dosed in Phase 1 Trial of First-in-Class Metabolic Checkpoint Antibody PLT012 in Solid Tumors

February 19, 2026

Pilatus Biosciences Receives FDA Fast Track Designation for Metabolic Checkpoint Inhibitor PLT012 in Hepatocellular Carcinoma

Upcoming Events

May 4, 2026

-

May 5, 2026

Basel

Swiss Biotech Day

More Info

May 11, 2026

-

May 12, 2026

Hong Kong

Asia Summit on Global Health

More Info

May 27, 2026

-

May 30, 2026

Barcelona

EASL Congress 2026

More Info

May 29, 2026

-

June 2, 2026

Chicago

ASCO Annual Meeting

More Info